Intravascular large B-cell lymphoma: report of three cases and analysis of the mTOR pathway.

about

Intravascular large B-cell lymphoma presenting as panniculitis.Intravascular Large B-Cell Lymphoma Presenting with Diffuse Gallbladder Wall Thickening: A Case Report and Literature Review.

P2860

Q47097370-0BDD96CB-87E9-4914-84A5-D94CA8C48CDF Q55091872-D8A2AF3A-10CC-4FE9-85BE-C81A96B5D35C

P2860

Intravascular large B-cell lymphoma: report of three cases and analysis of the mTOR pathway.

Item

http://www.wikidata.org/entity/Q35577880

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Intravascular large B-cell lym ...... analysis of the mTOR pathway.

@ast

Intravascular large B-cell lym ...... analysis of the mTOR pathway.

@en

type

Item

label

Intravascular large B-cell lym ...... analysis of the mTOR pathway.

@ast

Intravascular large B-cell lym ...... analysis of the mTOR pathway.

@en

prefLabel

Intravascular large B-cell lym ...... analysis of the mTOR pathway.

@ast

Intravascular large B-cell lym ...... analysis of the mTOR pathway.

@en

P1476

Intravascular large B-cell lym ...... d analysis of the mTOR pathway

@en

P2093

Angelo Lapus

http://www.w3.org/2001/XMLSchema#string

Lei Chen

http://www.w3.org/2001/XMLSchema#string

Nghia Nguyen

http://www.w3.org/2001/XMLSchema#string

Qi Shen

http://www.w3.org/2001/XMLSchema#string

Robert E Brown

http://www.w3.org/2001/XMLSchema#string

Wei Feng

http://www.w3.org/2001/XMLSchema#string

Xiuzhen Duan

http://www.w3.org/2001/XMLSchema#string

P2860

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma

mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events

Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions.

Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma

Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium

Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan.

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.

Intravascular lymphoma: a neoplasm of 'homeless' lymphocytes?

P304

782-790

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22135726

http://www.w3.org/2001/XMLSchema#string

P932

3225790

http://www.w3.org/2001/XMLSchema#string

Intravascular large B-cell lymphoma: report of three cases and analysis of the mTOR pathway.

about

P2860

P2860

Intravascular large B-cell lymphoma: report of three cases and analysis of the mTOR pathway.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932